FIELD: medicine.
SUBSTANCE: with the underlying conventional drug therapy, the patient is exposed to millimetre-wave electromagnetic emission at the molecular spectrum frequencies of oxygen emission and absorption spectra with the exposure localised within the xiphoid appendix. The exposure time is 3 minutes continuously within one session. The output emissive power is 500 mcW at the power density on the skin surface of 17.4 mcW/cm2. A distance of the exposure point and an object is specified to be equal to 4 cm. The therapeutic course makes 7-10 sessions, one session a day.
EFFECT: higher therapeutic effectiveness in patients with angina or arterial hypertension ensured by the antihypertensive and antianginal effect resulted from the specified mode of the terahertz exposure.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CARDIOVASCULAR DISEASE CASES | 2005 |
|
RU2286185C2 |
METHOD OF STRESS DISTURBANCE NORMALISATION IN BLOOD RHEOLOGY IN VIVO IN EXPERIMENT | 2009 |
|
RU2398606C1 |
METHOD FOR NORMALISING ABNORMAL BLOOD NITRITE CONCENTRATION | 2010 |
|
RU2414937C1 |
METHOD FOR DECREASING THE INCREASED FUNCTIONAL ACTIVITY OF THROMBOCYTES IN VIVO IN AN EXPERIMENT | 2006 |
|
RU2315553C1 |
METHOD OF REDUCING INCREASE ENDOTHELIN I PRODUCTION IN CONDITIONS OF STRESS | 2009 |
|
RU2394612C1 |
METHOD OF LOWERED CONCENTRATION OF NITRITES IN BLOOD PLASMA IN CONDITIONS OF STRESS RESTORATION | 2007 |
|
RU2342961C1 |
METHOD OF EXPERIMENTAL BLOOD FLOW LINEAR VELOCITY NORMALISATION IN GREAT VESSELS ASSOCIATED WITH ACUTE STRESS-REACTION | 2006 |
|
RU2327493C1 |
METHOD OF REDUCTION OF INCREASED FUNCTIONAL ACTIVITY IN ADRENAL GLAND CORTEX FOR EXPERIMENT IN VIVO | 2007 |
|
RU2349353C2 |
METHOD FOR TREATING ANGINA PECTORIS PATIENTS | 1994 |
|
RU2086269C1 |
METHOD OF RESTORING DISTURBED FIBRINOLYTIC ACTIVITY OF BLOOD IN EXPERIMENT | 2009 |
|
RU2391123C1 |
Authors
Dates
2014-12-20—Published
2012-12-27—Filed